Monday, April 10, 2017 12:23:14 PM
Below is a link to a shareholder communication with the two transdermal delivery system inventors: Steven J. Keough and Howard Phillips. Otiko works with Phillips.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129232062
They had to alter the formula for Viabecline to avoid similarities with Diabecline as the Diabecline Trademark is held by Keough. The ingredients are noted in my section of the iBox. Diabecline won the Edison Award in 2012.
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM